Research team affirms useful blood biomarker for group of brain disorders in new study

Research team affirms useful blood biomarker for group of brain disorders in new study

A test of protein in the blood is receiving further support as a biomarker for patients diagnosed with frontotemporal dementia (FTD), a group of brain disorders with few treatment options. These disorders are characterized by changes in behavior, cognition, language or movement.

Comments are closed.

Smartwatches and fitness bands reveal individual physiological responses to COVID-19 vaccine
19 April 2022
When severe infection causes long-term mood disorders: Researchers identify promising treatment path
20 April 2022